Noticias sobre Multiple myeloma | Hospital Clínic Barcelona

Clínic Barcelona

Research December 17 2021

Hospital Clínic-IDIBAPS has developed a CAR-T cell therapy for multiple myeloma that shows an effectiveness of over 70% after one-year follow-up

The Hospital Clínic-IDIBAPS has developed the first CAR T-cell therapy in Europe to treat multiple myeloma, the second most common type of blood canc1

Clínic Barcelona

Research November 11 2021

The AECC awards Hospital Clínic-IDIBAPS 2.1 million euros for cancer research

On Thursday, 11 November, the Spanish Cancer Association (AECC) awarded the AECC 2021 Grants for Cancer Research at an event held at the organization1

Clínic Barcelona

Health Topics July 2 2020

Coronavirus has a more serious impact on patients with haematological diseases

People who have a haematological disease, such as lymphoma or leukaemia, present a state of immunosuppression caused both by the illness itself and t1

Clínic Barcelona

Health Topics December 13 2019

Immunotherapy: an innovative and efficient tool in the battle against haematological tumours

In recent years, one of the strategies developed in the field of haematology is the modification of the patient’s immune system, also known as ‘immun1

Clínic Barcelona

Healthcare July 29 2019

Home treatment improves the quality of life in myeloma patients

Patients with multiple myeloma and mobility problems who receive treatment at home improve their quality of life by avoiding repeated visits to the h1

News about Multiple myeloma

Hospital Clínic-IDIBAPS has developed a CAR-T cell therapy for multiple myeloma that shows an effectiveness of over 70% after one-year follow-up

The AECC awards Hospital Clínic-IDIBAPS 2.1 million euros for cancer research

Coronavirus has a more serious impact on patients with haematological diseases

Immunotherapy: an innovative and efficient tool in the battle against haematological tumours

Home treatment improves the quality of life in myeloma patients

Subscribe to the Newsletter of Clínic